Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

Upadacitinib effectively treats psoriasis and lichen planus together.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

New treatments for severe alopecia areata show promise but lack standard approval.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.